Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))

Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). It can be used for the research of multiple sclerosis. MW: 144.56 KD.

• Supplier: Selleck Chemicals
• Product #: A2988
• Sku #: A2988-1mg*5